Diabetes control read more is a constant challenge for millions worldwide. Novel advancements in pharmaceutical research have brought forth two promising medications, tirzepatide and semaglutide, which hold the potential to revolutionize diabetes care. These medications, belonging to the class of glucagon-like peptide-1 (GLP-1) receptor agonists,